Dynamic Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Sell
68,055
-77
-0.1% -$2.01K 1.24% 11
2026
Q1
$1.91M Buy
68,132
+6,964
+11% +$185K 1.56% 11
2025
Q4
$1.52M Sell
61,168
-1,513
-2% -$38.2K 1.3% 11
2025
Q3
$1.6M Buy
62,681
+242
+0.4% +$5.97K 1.39% 9
2025
Q2
$1.51M Buy
62,439
+1,874
+3% +$43.7K 1.46% 9
2025
Q1
$1.53M Buy
60,565
+1,536
+3% +$40.2K 1.54% 7
2024
Q4
$1.57M Buy
+59,029
New +$1.6M 1.59% 7

Other funds holding PFE

Dynamic Financial Group's PFE Position: Q2 2026 in Review

Dynamic Financial Group reduced its Pfizer (PFE) stake by 0.11% in Q2 2026, selling an estimated $2.01K and leaving 68,055 shares worth $1.64M. The position accounts for 1.24% of the portfolio, ranked #11.

Dynamic Financial Group first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.91M in Q1 2026. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Dynamic Financial Group held 68,055 shares of Pfizer worth $1.64M as of Q2 2026.
  • Dynamic Financial Group sold 77 Pfizer shares in Q2 2026, an estimated $2.01K.
  • Pfizer made up 1.24% of Dynamic Financial Group's portfolio in Q2 2026, its #11 holding.
  • Dynamic Financial Group first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Dynamic Financial Group's Pfizer position peaked at $1.91M in Q1 2026.
  • 2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Dynamic Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.